108 related articles for article (PubMed ID: 9130606)
1. Correlation between HLA-DR expression and level of poly(ADP-ribose) synthetase in human thyroid carcinoma cells.
Shinohara M; Morisawa K; Ota K; Qu Z; Takeda K; Hashimoto K; Tomoda T; Kurashige T; Taniguchi T
Cell Mol Biol (Noisy-le-grand); 1997 Mar; 43(2):227-35. PubMed ID: 9130606
[TBL] [Abstract][Full Text] [Related]
2. Participation of poly(ADP-ribose) synthetase in the process of norepinephrine-induced inhibition of major histocompatibility complex class II antigen expression in human astrocytoma cells.
Taniguchi T; Nemoto Y; Ota K; Imai T; Tobari J
Biochem Biophys Res Commun; 1993 Jun; 193(3):886-9. PubMed ID: 8323563
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of interferon-gamma-induced major histocompatibility complex class II gene expression by expressing an antisense RNA of poly(ADP-ribose) synthetase.
Qu Z; Fujimoto S; Taniguchi T
J Biol Chem; 1994 Feb; 269(8):5543-7. PubMed ID: 8119888
[TBL] [Abstract][Full Text] [Related]
4. Control of HLA-DR antigen expression by gamma-interferon: separate signal transduction mechanisms in malignant and nonmalignant human thyroid cells.
Lahat N; Sobel E; Kraiem Z
Cancer Res; 1993 Sep; 53(17):3943-7. PubMed ID: 8358721
[TBL] [Abstract][Full Text] [Related]
5. [Spontaneous expression of class II (HLA-DR) molecules in thyroid pathology].
Aguayo J; Pérez MV; Trincado P; Wohllk N; Pineda G
Rev Med Chil; 1991 Aug; 119(8):867-70. PubMed ID: 1844766
[TBL] [Abstract][Full Text] [Related]
6. Regulation of HLA-DR and costimulatory B7 molecules in human thyroid carcinoma cells: differential binding of transcription factors to the HLA-DRalpha promoter.
Lahat N; Rahat MA; Sadeh O; Kinarty A; Kraiem Z
Thyroid; 1998 May; 8(5):361-9. PubMed ID: 9623725
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of interferon-gamma- and phorbol ester-induced HLA-DR and interleukin-1 production by the expression of a transfected poly(ADP-ribose) synthetase gene in human leukemia THP-1 cells.
Tomoda T; Kurashige T; Taniguchi T
Biochim Biophys Acta; 1992 Apr; 1135(1):79-83. PubMed ID: 1317213
[TBL] [Abstract][Full Text] [Related]
8. HLA-DR expression in B-lymphocytes in vitro is not suppressed by the absence of exogenous antigens.
Park JH; Lee YJ; Na SY; Cho EW; Kim KL
Mol Cells; 2001 Oct; 12(2):164-72. PubMed ID: 11710516
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.
Satoh A; Toyota M; Ikeda H; Morimoto Y; Akino K; Mita H; Suzuki H; Sasaki Y; Kanaseki T; Takamura Y; Soejima H; Urano T; Yanagihara K; Endo T; Hinoda Y; Fujita M; Hosokawa M; Sato N; Tokino T; Imai K
Oncogene; 2004 Nov; 23(55):8876-86. PubMed ID: 15467734
[TBL] [Abstract][Full Text] [Related]
10. HLA-D subregion expression by thyroid epithelium in autoimmune thyroid diseases and induced in vitro.
Todd I; Pujol-Borrell R; Abdul-Karim BA; Hammond LJ; Feldmann M; Bottazzo GF
Clin Exp Immunol; 1987 Sep; 69(3):532-42. PubMed ID: 3117460
[TBL] [Abstract][Full Text] [Related]
11. Statins decrease the aberrant HLA-DR expression on thyrocytes from patients with Hashimoto's thyroiditis.
Wu X; Schott M; Liu C; Qian C; Mao X; Xu K; Jiang J; Xu Y; Shen M; Papewalis C; Scherbaum WA; Liu C
Horm Metab Res; 2008 Dec; 40(12):838-41. PubMed ID: 18686224
[TBL] [Abstract][Full Text] [Related]
12. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.
Muczynski KA; Anderson SK; Pious D
J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276
[TBL] [Abstract][Full Text] [Related]
13. A caspase-independent pathway of MHC class II antigen-mediated apoptosis of human B lymphocytes.
Drénou B; Blancheteau V; Burgess DH; Fauchet R; Charron DJ; Mooney NA
J Immunol; 1999 Oct; 163(8):4115-24. PubMed ID: 10510346
[TBL] [Abstract][Full Text] [Related]
14. Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancer.
Yazawa T; Kamma H; Fujiwara M; Matsui M; Horiguchi H; Satoh H; Fujimoto M; Yokoyama K; Ogata T
J Pathol; 1999 Jan; 187(2):191-9. PubMed ID: 10365094
[TBL] [Abstract][Full Text] [Related]
15. Potentiation by thyroid hormone of human IFN-gamma-induced HLA-DR expression.
Lin HY; Martino LJ; Wilcox BD; Davis FB; Gordinier JK; Davis PJ
J Immunol; 1998 Jul; 161(2):843-9. PubMed ID: 9670962
[TBL] [Abstract][Full Text] [Related]
16. HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA: acquisition of antigen processing and presentation capacity.
Sartoris S; Valle MT; Barbaro AL; Tosi G; Cestari T; D'Agostino A; Megiovanni AM; Manca F; Accolla RS
J Immunol; 1998 Jul; 161(2):814-20. PubMed ID: 9670958
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma induces apoptosis and expression of inflammation-related proteins in Chang conjunctival cells.
De Saint Jean M; Brignole F; Feldmann G; Goguel A; Baudouin C
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2199-212. PubMed ID: 10476784
[TBL] [Abstract][Full Text] [Related]
18. CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cells.
Meissner M; Whiteside TL; Kaufmann R; Seliger B
Arch Dermatol Res; 2009 Feb; 301(2):189-93. PubMed ID: 19104823
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy for prostate cancer by targeting poly(ADP-ribose) polymerase.
Trofimova I; Dimtchev A; Jung M; Rosenthal D; Smulson M; Dritschilo A; Soldatenkov V
Cancer Res; 2002 Dec; 62(23):6879-83. PubMed ID: 12460902
[TBL] [Abstract][Full Text] [Related]
20. Effect of poly(ADP-ribose) synthetase on the expression of major histocompatibility complex (MHC) class II genes.
Taniguchi T; Ota K; Qu Z; Morisawa K
Biochimie; 1995; 77(6):472-9. PubMed ID: 7578432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
